| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |